The article “A Darwinian View of
the Hygiene or ‘Old Friends’ Hypothesis” by Graham A.W Rook details the
specific outcomes of research that supports the hygiene hypothesis. This
hypothesis states that some autoimmune diseases are becoming more prevalent in
developed areas due to the lack of exposure to pathogens at a young age. This
is due as the lack of pathogen exposure suppresses the natural progression of
the immune system and causes a lower degree of immune tolerance. The article
“For the Good of the Gut: Can Parasitic Worms Treat Autoimmune Diseases?” by
Ferris Jabr elaborates on a specific field of research that is associated with
the hygiene hypothesis. Jabr focuses on
the ingestion of parasitic worms to decrease the symptoms associated with
gastrointestinal diseases.
In the article by Jabr, it was
mentioned that the use of whipworms completely treated the symptoms of a man’s
colitis. The article then continues with additional data that supports the use
of helminthic therapy without listing any of its’ drawbacks. When reading the
article, I initially believed that the whipworm parasite was just a benign worm
that probably just hung around in the intestines for a little bit before being
passed out without causing any symptoms. However, a quick online search shows
that while light infestations of less that 100 worms are usually symptomless
(the examples of helminthic therapies in the article used up from 1000-3000
worms), anything more than that number may cause additional GI symptoms such as
abdominal pain, bloody diarrhea, and even bacterial infections from the worms
penetrating the intestinal lining. These symptoms are for acute expose to the
worms only, but seeing as the worm eggs in helminthic therapy need to be
reintroduced continually in order to remain symptom free (from the autoimmune
disease), it is possible that more serious chronic symptoms can occur. This is
why I don’t think helminthic therapy will be a viable option in the future
mainly because the costs outweigh the benefits.
However, in the article by Rook he
states that the GI microbiota also exert a degree of immunoregulatory control.
Because the bacteria in the gut flora is so numerous and has a great deal of
diversity/ variation from person to person, it presents a better target in developing
therapies against autoimmune diseases. Specifically in determining which
species of bacteria are helpful in reducing the symptoms of certain diseases
and which species exacerbate the symptoms.